Zynerba Pharmaceuticals Inc. (ZYNE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-08
7:22 pm
Sale
2023-12-3113GZYNERBA PHARMACEUTICALS INC CO
ZYNE
Beryl Capital Management LLC0
0.000%
-4,426,381decrease
(Position Closed)
Filing
History
2023-09-05
4:39 pm
Purchase
2023-08-2413GZYNERBA PHARMACEUTICALS INC CO
ZYNE
Beryl Capital Management LLC4,426,381
8.200%
4,426,381increase
(New Position)
Filing
History
2023-08-24
5:23 pm
Purchase
2023-08-1413DZYNERBA PHARMACEUTICALS INC CO
ZYNE
Harmony Biosciences Holdings Inc.
HRMY
7,592,498
13.130%
7,592,498increase
(New Position)
Filing
History
2022-02-14
3:52 pm
Sale
2022-02-1113GZYNERBA PHARMACEUTICALS INC CO
ZYNE
ETF MANAGERS GROUP LLC3,526,304
8.560%
-1,087,028decrease
(-23.56%)
Filing
History